FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira METRONIDazole Injection Recall

METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag, Rx only, Hospira, Inc

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Mar 27, 2013
Recall ID
D-206-2013
Check your lot numberHow we source this data

Summary

Hospira recalled METRONIDazole Injection starting Feb 15, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-206-2013 on Mar 27, 2013. Reason: Lack of Assurance of Sterility: There is the potential for the solution to leak from the administrative port to the fill tube seal. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: There is the potential for the solution to leak from the administrative port to the fill tube seal.

Product description

METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag, Rx only, Hospira, Inc. Lake Forest, IL 60045 (NDC 0409-7811-24)

Lot numbers, UPCs & expiration codes

Lot code 12-074-JT Exp 12/13

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-206-2013
Classification
Class II
Status
Terminated
Recall initiated
Feb 15, 2013
FDA report date
Mar 27, 2013
Quantity
567,624 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-206-2013, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
64482
Address
275 N Field Dr
Code information
Lot code 12-074-JT Exp 12/13
Postal code
60045-2579
Report date
Mar 27, 2013
Product type
Drugs
Recall number
D-206-2013
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
567,624 bags
Termination date
Mar 31, 2015
Reason for recall
Lack of Assurance of Sterility: There is the potential for the solution to leak from the administrative port to the fill tube seal.
Voluntary / mandated
Voluntary: Firm initiated
Product description
METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag, Rx only, Hospira, Inc. Lake Forest, IL 60045 (NDC 0409-7811-24)
Distribution pattern
Nationwide.
Recall initiation date
Feb 15, 2013
Initial firm notification
Letter
Center classification date
Mar 21, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-206-2013, published Mar 27, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls